| Vancouver Prostate Centre | |
|---|---|
| Motto | Research. Treatment. |
| Formation | 1998[1] |
| Type | Cancer Research |
| Headquarters | Vancouver, British Columbia |
| Location | Canada |
| Executive Director | Dr. Martin Gleave |
| Director of Development | Dr. Larry Goldenberg |
| Director of Laboratory Research | Dr. Paul Rennie |
| Chief Operating Officer | Dr. Graeme Boniface |
| Parent organization | Vancouver Coastal Health |
| Staff | 150 |
| Website | Vancouver Prostate Centre |
| Former name | The Prostate Centre at VGH |
The Vancouver Prostate Centre (VPC) is a prostate cancer research centre located in Vancouver, British Columbia. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.[2] It is one of the major research facilities of Vancouver Coastal Health and Vancouver General Hospital.[3]
Contents |
The Vancouver Prostate Centre was founded in 1998 by Larry Goldenberg aided with a $20 million dollar donation by Vancouver businessman Jim Pattison. The Centre was first located in the Jack Bell Research Centre adjacent to Vancouver General Hospital. In 2011, it expanded its laboratories to encompass the new Robert H. N. Ho Research Centre as well.[4] The mission of the Centre is to "is to foster the paradigm of team-driven translational health research to discover molecular mechanisms of cancer progression and therapeutic resistance."[5]
The Vancouver Prostate Centre is hosted by the Vancouver Coastal Health Research Institute and the University of British Columbia, and receives substantial financial support from the VGH and UBC Hospital Foundation.[6] The Centre employs more than 150 people, including 10 Principal Investigators, in three facilities: a research laboratory located at Jack Bell Research Centre and the Robert H. N. Ho Centre, a clinic and clinical trials centre, and an education resource centre. The transdisciplinary team at The Prostate Centre includes experts in genomics, proteomics, bioinformatics, pathology, translational biology and oncology.[7]
On November 2, 2011, the Terry Fox Foundation announced that it woud donate over $6 million dollars to the Vancouver Prostate Centre to fund research on castration-resistant prostate cancer.[8]